AD/PD - Advances in Science & Therapy

Earn points by completing courses & webinars and engaging in discussions on AD/PD™ Education on UNLOK. Climb the leaderboard for a chance to win exclusive prizes such as free AD/PD™ 2027 tickets! 🧑‍💻 Find out more at the AD/PD™ booth or at ➡️  unlok-education.com/ad-pd/ #alzheimers #parkinsons #dementia #endalz #neuroscience

Breaking New Ground in Alzheimer’s Research at #ADPD2026! 🔬 @cesar_vogado, PhD Fellow at the @novonordisk Foundation Center for Basic Metabolic Research, shares his exciting insights on "Genomic partitioning of Alzheimer's disease reveals non-CNS etiology in humans". His research focuses on the systemic factors driving AD, emphasizing the role of immune and metabolic processes in the disease. 🧠✨ #Neuroscience #MetabolicResearch #ImmuneSystem #Genomics #NeurodegenerativeDiseases

#ADPD2026 | Our first interview of the day is with Dr Robert Vassar - he shared mechanistic insights into the connection between amyloid-beta and tau, therapeutic strategies to prevent #AlzheimersDisease, & more! Coming soon to VJDementia.com!👀 @adpdnet #Dementia

Massive thanks to @smartinezho1 for stopping by at #ADPD2026! He discussed: 👉The new PI‑2620 tau-PET tracer 👉A study using this tracer to detect early tau deposition in Huntington’s disease 👉Non-pharmacological approaches to Parkinson's disease & more! Full interview coming soon📹 @adpdnet #Dementia #Alzheimers

Professor Johannes Attems, Professor of Neuropathology and member of the PSPA Research Committee chaired a session and presented at #ADPD2026 yesterday. His session was called ‘Linking Pathology and Biomarkers across Neurodegenerative #Disorders’ which looked at PSP & CBD.

#ADPD2026: Plenary Lecture 05 🔬 This morning, Dr. Aviv Regev delivered a powerful plenary lecture on the journey from cell atlases to medicines using #AI! 🌐💡 In this groundbreaking talk, Dr. Regev explored how single-cell and spatial genomics atlases are revolutionizing the understanding of neurodegenerative diseases, enabling us to place genetic risk alleles in their cellular and tissue context. 🧠 It was an inspiring session that showed how AI is accelerating the discovery of new therapies for Alzheimer's, Parkinson’s, and other neurodegenerative disorders. 🔍✨ Stay tuned for more breakthroughs as #ADPD2026 unfolds! 🌟 #Neuroscience #AI #NeurodegenerativeDiseases #ResearchInnovation

🙌 Day 4 of #ADPD2026 has arrived! Kick off your day in📍Hall A1 with the Plenary Lecture by Aviv Regev, "From Cell Atlases to Medicines, with AI" at 08:00 AM. Following that, Parallel Sessions begin at 08:40 AM in various halls, diving into key topics such as: ✅ Molecular Neuroinflammation Pathways ✅ Synaptic Dysfunction and Biomarkers in AD/PD ✅ APOE4 Distinct Signature in AD and PD ✅ Genetics, APOE, and Lipid Pathways in AD …and more! 💬 What are you most excited about for Day 4? 🤓 Let’s make today another day full of learning, innovation, and collaboration! #Parkinsons #NeurodegenerativeDiseases #ResearchInnovation #Neuroinflammation

@PhylFerrell 👏

The #GOAT (for those of us in #Alzheimers research) IYKYK #ADPD2026 @adpdnet

A massive thank you to Dr David Watson for speaking with us at #ADPD2026 today! He discussed the Phase III APOLLOE4 trial (NCT04770220) of valiltramiprosate, delving into the unmet need for APOE homozygous Alzheimer's and the potential of combining this agent with anti-amyloid therapies. Stay tuned for this insightful interview!🎥 @adpdnet #Neurology #AlzheimersDisease #NeuroTwitter

#ADPD2026: Day 3 Highlights, Reflections, and Excitement from Copenhagen! 🌍✨ @iampriyasuman, Ph.D. Candidate in Neuroscience at @uOttawa Research Institute, and Selin Posacıoğlu, Senior IB Student at The Koç School, shared their highlights from today's sessions. Don’t miss the chance to hear more from these rising stars in the field! 🌟 Watch the full recap and get ready for even more tomorrow! #Neuroscience #Alzheimers #Parkinsons #ResearchInnovation #ADPD2026

🤩Day three at AD/PD™ 2026 was a whirlwind of groundbreaking scientific discoveries, innovative treatments, and thought-provoking discussions. With thousands of leading experts from around the globe gathered in Copenhagen, the conference continues to drive progress in the fight against neurodegenerative diseases, paving the way for a brighter future for Alzheimer's and Parkinson's patients worldwide. Let us know what you think of the program on Instagram, LinkedIn, Facebook, and X using #ADPD2026! 🌆See you again tomorrow for the penultimate day of the Conference!

📸🤳Show Us Your AD/PD™ Experience in Copenhagen! Share your favorite moments, whether it’s a photo of a session, networking with peers, or the energy of the conference. Use #ADPD2026 for a chance to win a free registration for AD/PD™ 2027! 👏 We’re excited to celebrate the experiences and memories from Copenhagen 2026! 🔗 adpd.kenes.com/adpd2026-photo… #ADPD2026 #PhotoContest #Copenhagen2026 #Neuroscience #Alzheimers #Parkinsons

Inspiring Words from @YentliSA, at #ADPD2026! 👏 We are thrilled to have Yentli, an MD-PhD candidate at University of Pennsylvania, back with us at #ADPD2026! Last year in Vienna, Yentli attended the conference and made meaningful connections, which led to exciting collaborations and new projects she’s working on today. 🌟 AD/PD™ played a pivotal role in her career path, opening doors to new collaborations and inspiring her work towards finding better treatments for these devastating diseases. 🎥 Watch the full recap video to hear more from Yentli as she shares her inspiring vision for tackling ALS and FTD. @TargetALS_fdn @BrainXell_Inc @esrfsynchrotron💯 #alzheimers #dementia

Day 3 of #ADPD2026 Kicked Off with a Powerful Plenary Lecture! ✨@michael_heneka This morning, #ADPD2026 began with an insightful session by Professor Michael T. Heneka from Luxembourg, presenting “Innate Immunity as Treatment Target in Alzheimer’s Disease”. 🧠🔬 The session explored the role of innate immunity in Alzheimer’s disease and its potential as a treatment target-an exciting area of research that could pave the way for innovative therapies! 💡 Stay tuned for more highlights and discoveries throughout the day! #Neuroscience #Alzheimers #NeurodegenerativeDiseases #InnateImmunity

📍¡Seguimos en el @adpdnet! #ADPD2026 El equipo de la Fundación Pasqual Maragall y el @BarcelonaBeta participa con ponencias, presentaciones y pósteres, abordando los avances más recientes en la investigación del #Alzheimer. 🧠